2m 2m 2m 2m 2m 2m 2m
LEXEO (LXEO)
NASDAQ
$2.90-$0.10 (-3.50%)
Price as of Oct 22, 2026 7:30 PM EDT- $246.3MMarket Cap
- -67.50%1-Year Change
- BiotechnologyIndustry
LEXEO (LXEO)
$2.90-$0.10 (-3.50%)
LXEO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.00 | ||
Change | -$0.02 (-0.66%) | ||
Open | $3.03 | ||
High | $3.09 | ||
Low | $2.97 | ||
Previous Close | $3.02 | ||
Volume | 1,080,345 | ||
30-Day Average Volume | 1,996,531 | ||
1-Week Change | 14.07% | ||
1-Month Change | -26.47% | ||
1-Year Change | -67.50% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 82.1M | ||
Total Assets | $254.9M | ||
Market Cap | $246.3M | ||
Enterprise Value | $153.4M | ||
Period: QTR TTM FY | |||
Revenue | -$156,000.00 | ||
Net Income | -$25.9M | ||
Free Cash Flow | -$17.6M | ||
EBIT | -$25.9M | ||
EBITDA | -$25.8M | ||
Net Working Capital | $202.2M | ||
EPS | -$0.30 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | -984 | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | 0 | ||
Price/Free Cash Flow | -14 | ||
Price/Operating Cash Flow | -14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue